Company Filing History:
Years Active: 2010
Title: Innovations by Inventor Jin Sook Kim from Daejeon, KR
Introduction: Jin Sook Kim is an accomplished inventor based in Daejeon, South Korea. He holds a significant patent that contributes to the field of biotechnology, specifically targeting cancer-related research. With his work at the Korea Research Institute of Bioscience and Biotechnology, Jin Sook Kim continues to make strides in medical innovation.
Latest Patents: Jin Sook Kim holds one notable patent which relates to a monoclonal antibody specific for the N-myc downstream regulated gene 2 (NDRG 2) protein. This invention includes a cell line producing the monoclonal antibody, a method for measuring the quantity and quality of NDRG 2 protein, and a protein chip employing this technology. The NDRG 2 protein, being a cancer-related factor, is specifically expressed in dendritic cells differentiated from human peripheral blood monocytes. This patent aims to assist in elucidating characteristics of dendritic cells and could significantly contribute to the research and treatment of intractable diseases and cancers.
Career Highlights: Throughout his career, Jin Sook Kim has focused on innovations that bridge the gap between laboratory research and clinical applications. His expertise in monoclonal antibodies has positioned him as a key figure in developing therapies that target specific proteins related to cancer. His commitment to advancing bioscience research has set a benchmark in the field.
Collaborations: Jin Sook Kim collaborates with esteemed colleagues such as Eun Young Song and Jae Wha Kim, contributing to a dynamic environment that fosters innovation at the Korea Research Institute of Bioscience and Biotechnology. Together, they are committed to exploring new frontiers in biotechnology and improving methodologies in cancer research.
Conclusion: Jin Sook Kim’s contributions through his patent and collaborative efforts are instrumental in the advancement of cancer research and biotechnology. His innovative work at the Korea Research Institute of Bioscience and Biotechnology not only highlights his commitment to scientific discovery but also paves the way for future breakthroughs in treating complex diseases.